RxDoctor Payments DataLook up a doctor →

Constance Irick, MD

Family Medicine · Olathe, KSNPI 1346235272

Payments from drug & device makers

$19,855in general payments, 2019–2025

Across 1,446 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Pfizer$2K
  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$765
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)295$3,462
Pfizer175$2,034
AstraZeneca(2 entities)85$1,733
Novo Nordisk135$1,618
Lilly USA, LLC100$1,471
Boehringer Ingelheim45$765
GSK42$732
Amgen41$643
Amarin Pharma, Inc.42$484
Merck37$476
Biohaven Pharmaceutical Holding Company Ltd.38$461
Bayer23$401
Biohaven Pharmaceuticals, Inc.37$311
Takeda Pharmaceuticals U.S.A., Inc.20$290
Kowa Pharmaceuticals America, Inc.16$260
Upsher-smith Laboratories LLC22$238
Supernus Pharmaceuticals, Inc.15$229
Amneal Pharmaceuticals LLC13$226
Esperion Therapeutics, Inc.24$216
Sumitomo Pharma America, Inc.15$209
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$201
Sunovion Pharmaceuticals Inc.19$189
IBSA Pharma Inc.12$175
Johnson & Johnson12$171
Impel Pharmaceuticals Inc.11$157
Corium, LLC8$155
Teva Pharmaceuticals USA, Inc.10$153
Novartis8$148
Millicent US Inc6$127
Paratek Pharmaceuticals, Inc.6$110
Abbott6$110
Scilex Pharmaceuticals Inc.7$101
Daiichi Sankyo Inc.5$96
Zyla Life Sciences, Inc.7$96
Phathom Pharmaceuticals, Inc.5$95
Jazz Pharmaceuticals Inc.5$82
Axsome Therapeutics, Inc.4$78
Shield Therapeutics Inc3$76
Therapeuticsmd, Inc.5$72
Eisai Inc.5$70
Antares Pharma, Inc.4$64
Astellas Pharma US Inc3$63
Idorsia Pharmaceuticals US Inc3$59
Endo Pharmaceuticals Inc.4$55
Optinose US, Inc.3$54
Shire North American Group Inc3$52
Acella Pharmaceuticals, LLC3$52
Nevro Corp.2$46
Exact Sciences3$44
Currax Pharmaceuticals LLC3$43
Lundbeck LLC2$41
Almatica Pharma LLC2$40
Virtus Pharmaceuticals LLC2$38
Sanofi Pasteur Inc.2$38
Sanofi-aventis U.S. LLC2$38
Sanofi2$34
Myovant Sciences Inc.2$30
Azurity Pharmaceuticals, Inc.2$30
Genentech USA, Inc.2$29
Ironwood Pharmaceuticals, Inc2$28

How this compares

$19,855 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas →

Medicare billing

Part B allowed, 2024
$262,656
Medicare patients
338
Services billed
4,594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Olathe

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →